There are an estimated 140 000 cases of zoonotic tuberculosis each year that result in approximately 11 400 deaths.1 However, these estimates are subject to certain caveats, one of which is the definition of zoonotic tuberculosis. WHO, World Organisati...
The ongoing Israel–Hamas war in Gaza has led to a severe health crisis, notably affecting children younger than 5 years with a substantial increase in infectious diseases. The situation is dire, with a UN report indicating around 179 000 acute respirat...
Bosh-Nicolau P, Fernandez ML, Sulleiro E, et al. Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial. Lancet Infect Dis 2024; published o...
Malembaka EB, Bugeme PM, Hutchins C, et al. Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study. Lancet Infect Dis 2024; published online Jan 18. https:/...
Malembaka EB, Bugeme PM, Hutchins C, et al. Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study. Lancet Infect Dis 2024; published online Jan 18. https:/...
Since its discovery in 1955, the incidence and geographical spread of reported Oropouche virus (OROV) infections have increased. Oropouche fever has been suggested to be one of the most important vector-borne diseases in Latin America. However, both li...
Masking was one of the most visible and prominent features of COVID-19. People who had never seen a facemask before started wearing them daily to curb the spread of the virus. In the recently published book, Social and ethical issues of global pandemic...
In The public health approach: population thinking from the Black Death to COVID-19, distinguished physician and epidemiologist Alfredo Morabia, advocates eloquently for what he terms a public health approach. Citing the 200 million Americans who were ...
We found no significant difference in estimated effectiveness of the two oral vaccines, supporting the recommendation that the more genetically stable nOPV2 should be preferred in cVDPV2 outbreak response. Our findings highlight the role of IPV and the...
A single dose of Euvichol-Plus provided substantial protection against medically attended cholera for at least 36 months after vaccination in this cholera-endemic setting. Although the evidence provides support for similar levels of protection in young...
Novel oral polio vaccine type 2 (nOPV2) has been genetically engineered to reduce the reversion events that can occur with Sabin oral polio vaccine (OPV) and result in loss of attenuation.1 As population immunity fell following the global withdrawal of...
A mass vaccination campaign with killed oral cholera vaccine (kOCV; Euvichol-Plus, EuBiologics, Seoul, South Korea) was conducted in an urban population vulnerable to cholera on the shores of Lake Tanganyika in the Democratic Republic of the Congo, fol...
Oral switch antimicrobial therapy was non-inferior to intravenous standard therapy in participants with low-risk S aureus bloodstream infection. However, it is necessary to carefully assess patients for signs and symptoms of complicated S aureus bloods...
In the October issue of The Lancet Infectious Diseases, the editorial titled Can We Control Dengue?1 takes into consideration only two aspects of dengue control: prevention by vaccination and vector control strategies. However, a very important aspect ...
As the costs and complexity of health-care delivery mount globally, there continues to be substantial interest in the use of oral antibiotic therapy for serious infections. In The Lancet Infectious Diseases, Achim Kaasch and colleagues1 evaluated the e...
I read with interest the Correspondence by Mathieu Nacher and colleagues1 in which the authors described subjecting ChatGPT3.5 to various vignettes that were reconstituted from confirmed cases of histoplasmosis in their cohort of people with HIV or HIV...